Novo Nordisk A S (NONOF) stock
NONOFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVO
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$38.24−0.60 (-1.53%)
Close on Oct 19, 2026Market cap $170.76BP/E 11.1Yield –
Novo Nordisk A S EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Novo Nordisk A S's EV/EBITDA was 9.2× on Nov 3, 2026, against 11.0× a year earlier. Over the last 5 years it ranged from 8.3× to 45.3×, with a median of 30.7×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 3, 2026 | 9.2× | −2.0 |
| 2025 | Dec 31, 2025 | 11.2× | −14.1 |
| 2024 | Dec 31, 2024 | 25.3× | −13.4 |
| 2023 | Dec 29, 2023 | 38.7× | +1.2 |
| 2022 | Dec 30, 2022 | 37.6× | +5.5 |
| 2021 | Dec 31, 2021 | 32.1× | +12.8 |
| 2020 | Dec 31, 2020 | 19.3× | −0.2 |
| 2019 | Dec 31, 2019 | 19.5× | +4.6 |
| 2018 | Dec 31, 2018 | 14.9× | −2.1 |
| 2017 | Dec 29, 2017 | 17.0× | +4.2 |
| 2016 | Dec 30, 2016 | 12.9× | – |
See a number that looks wrong?